Aspira Pathlab & Diagnostics L (ASPIRA)

BSE: ₹123.00
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Revenue from Operations 4.64 6.18 5.41 5.78 5.25
YOY Revenue Growth % - - - - 13.17%
Other Income 0.09 0.08 0.09 0.13 0.11
Total Income 4.73 6.25 5.50 5.91 5.36
Total Expenses + 4.75 5.26 5.12 5.18 4.89
Cost of Materials Consumed 0.88 1.10 0.85 0.87 0.90
Employee Benefit Expense 1.66 1.75 1.97 1.94 1.89
Other Expenses 1.75 1.97 1.82 1.91 1.64
Operating Profit -0.11 0.91 0.29 0.59 0.36
OPM % -2.3% 14.8% 5.3% 10.3% 6.9%
Profit Before Tax + -0.02 0.99 0.31 0.68 0.47
Tax Expense -0.06 0.00 0.00 0.00 0.05
Tax % - 0% 0% 0% 10.2%
Profit After Tax 0.05 0.99 0.31 0.68 0.42
EPS (Basic) 0.10 0.96 0.30 0.66 0.41

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025
Revenue from Operations 22.00
YOY Revenue Growth % -
Other Income 0.39
Total Income 22.39
Total Expenses + 20.32
Cost of Materials Consumed 3.70
Employee Benefit Expense 7.33
Other Expenses 7.45
Operating Profit 1.68
OPM % 7.7%
Profit Before Exceptional 2.07
Exceptional Items -0.05
Profit Before Tax + 2.02
Tax Expense 0.00
Tax % 0%
Profit After Tax 2.02
EPS (Basic) 1.97

Balance Sheet

Particulars Mar 2025
ASSETS
Non-Current Assets + 12.10
Property, Plant & Equipment 3.86
Capital Work in Progress 0.00
Non-Current Investments 0.00
Goodwill 2.65
Other Intangible Assets 0.01
Current Assets + 5.36
Inventories 0.51
Trade Receivables 2.35
Cash and Cash Equivalents 1.75
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 12.17
Equity Share Capital 10.29
Other Equity 1.87
Non-Current Liabilities 2.92
Current Liabilities 2.37
Total Liabilities 5.30

Cash Flow Statement

Particulars Mar 2025
Cash from Operating Activities 1.83
Cash from Investing Activities 0.12
Cash from Financing Activities -0.99
Net Increase/Decrease in Cash 0.95